Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,331 public trials 1,293 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Recruiting

Study of AHB-171 in Chronic Hepatitis B Participants

NCT07630727

Conditions
Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +20 more
Locations
  • AusperBio Investigational Site Beijing, Beijing Municipality, China
  • AusperBio Investigational Site Chongqing, Chongqing Municipality, China
  • AusperBio Investigational Site Xiamen, Fujian, China
  • AusperBio Investigational Site Guangzhou, Guangdong, China
View Trial Details
Recruiting

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

NCT07717437

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Monash Medical Centre Clayton, Victoria, Australia
View all 31 locations
View Trial Details
Recruiting

Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Secondary to Alpha-1-anti-tripsin Deficiency

NCT07715617

Conditions
Alpha-1-antitrypsin Deficiency, Artificial Intelligence (AI), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Hospices Civils de Lyon Bron, France
  • CHU de Lille Lille, France
  • Hôpital BICHAT CLAUDE-BERNARD Paris, France
  • Bordeaux University Hospital Pessac, France
View Trial Details
Recruiting

A Phase 1 Study of the Safety and Tolerability of CTX-10726

NCT07419841

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
  • START New York Lake Success, New York, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

NCT06051617

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • St. Joseph's Hospital and Medical Center - 350 W. Thomas Phoenix, Arizona, United States
  • OM Research LLC Lancaster, California, United States
  • SCPMG/Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States
View all 205 locations
View Trial Details
Recruiting

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

NCT07284121

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • Landesklinikum Krems Krems, Austria
  • Ordensklinikum Linz Elisabethinen Linz, Austria
  • Krankenhaus Nord - Klinik Floridsdorf Vienna, Austria
  • Klinikum Wels-Grieskirchen Wels, Austria
View all 91 locations
View Trial Details
Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

NCT07024641

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations
  • Grifols Investigative site Chandler, Arizona, United States
  • Grifols Investigative site Huntington Beach, California, United States
  • Grifols Investigative site Lake Forest, California, United States
  • Grifols Investigative site Long Beach, California, United States
View all 19 locations
View Trial Details

Related conditions